Psilos II

Psilos Group Managers, LLC is a New York-based venture capital firm founded in 1998 that specializes in investments in the healthcare sector, focusing on healthcare services, healthcare information technology, and medical technology. The firm primarily targets mid to later-stage and growth companies, typically investing in the second or third rounds of financing, with investment amounts ranging from $8 million to $15 million per deal. Psilos aims to be a lead or co-lead investor, acquiring significant stakes in its portfolio companies, and seeks to make a total investment of $20 million to $25 million over the life of each investment. With a strong emphasis on partnering with experienced management teams, Psilos looks for opportunities that promise enduring market value and a transformative impact on the healthcare landscape. The firm leverages its extensive network of relationships within the industry to enhance the strategic development of its investments.

Stephen M. Krupa

Managing Partner and CEO

Albert Waxman Ph.D

Founder and Senior Managing Director

32 past transactions

Gamma Medica

Series B in 2014
Gamma Medica, Inc. specializes in digital molecular imaging devices focused on early breast cancer detection. The company is recognized for its LumaGEM® MBI System, the first commercially available, FDA-cleared imaging system that employs cadmium zinc telluride (CZT) technology. This innovative planar, dual-head, fully solid-state system is designed to identify millimeter-sized breast cancers that are often overlooked by traditional mammography, particularly in women with dense breast tissue. In addition to the LumaGEM system, Gamma Medica offers a range of imaging technologies, including digital X-ray mammography, tomography, 3D mammography, and ultrasound systems, all aimed at enhancing screening capabilities for dense breast tissue and promoting early-stage cancer prevention.

Gamma Medica

Series A in 2013
Gamma Medica, Inc. specializes in digital molecular imaging devices focused on early breast cancer detection. The company is recognized for its LumaGEM® MBI System, the first commercially available, FDA-cleared imaging system that employs cadmium zinc telluride (CZT) technology. This innovative planar, dual-head, fully solid-state system is designed to identify millimeter-sized breast cancers that are often overlooked by traditional mammography, particularly in women with dense breast tissue. In addition to the LumaGEM system, Gamma Medica offers a range of imaging technologies, including digital X-ray mammography, tomography, 3D mammography, and ultrasound systems, all aimed at enhancing screening capabilities for dense breast tissue and promoting early-stage cancer prevention.

SeeChange Health

Series C in 2013
We provide the information, tools, and technology to help employees take control of their health, while companies take control of their health expenses. Whether you’re looking for flexible, self-administered health plans or customizable engagement software, our SeeChange Health Solutions make it easy to administer value-based benefits within your company.

SeeChange Health

Series B in 2011
We provide the information, tools, and technology to help employees take control of their health, while companies take control of their health expenses. Whether you’re looking for flexible, self-administered health plans or customizable engagement software, our SeeChange Health Solutions make it easy to administer value-based benefits within your company.

Gamma Medica-Ideas

Series A in 2009
Gamma Medica-Ideas (GM-I) develops novel technologies to markets that improve patient health through early diagnosis of disease, improved patient treatment and by enabling new drug discovery. GM-I also develops medical devices and techniques to support molecular imaging of living subjects, targeted at the pharmaceutical pre-clinical research and clinical diagnostic markets. GM-I is dedicated to developing cutting-edge, fully digital imaging systems using the most advanced solid-state technologies.

SeeChange Health

Series A in 2009
We provide the information, tools, and technology to help employees take control of their health, while companies take control of their health expenses. Whether you’re looking for flexible, self-administered health plans or customizable engagement software, our SeeChange Health Solutions make it easy to administer value-based benefits within your company.

VeraLight

Series C in 2008
VeraLight is a medical device company that was established in October 2004 to focus on a comprehensive approach to non-invasive type 2 diabetes and pre-diabetes screening with the proprietary SCOUT DS® system. Their mission is to help stem the tide of the worldwide diabetes epidemic by driving early diabetes detection, thus enabling initiation of therapies that can prevent diabetes or reduce its complications. The company develops and acquires intellectual property, products, and services that contribute to this mission.

OmniGuide

Series E in 2008
OmniGuide is a medical device company focused on developing and commercializing minimally invasive surgical tools that utilize CO2 laser technology. Their flagship product, the OmniGuide Beampath CO2 laser energy system, offers a compact solution for precise cutting, ablation, and coagulation, while minimizing thermal damage to surrounding healthy tissue. This versatile system is designed to enhance surgical outcomes by providing high-quality optical scalpels that improve clinical value and expand the possibilities of minimally invasive procedures. The company is dedicated to advancing patient care by delivering indication-specific surgical instruments and exceptional customer service, ultimately aiming to improve patients' quality of life. OmniGuide's products are cleared for sale in the United States and carry CE marking, reflecting their compliance with safety and efficacy standards.

HealthEdge

Venture Round in 2008
HealthEdge is a technology company that provides an integrated software platform specifically designed for healthcare payors. Its flagship product suite, HealthRules, incorporates modern technology to facilitate claims and benefits administration, care management, and business intelligence. By offering these capabilities, HealthEdge enables health insurers to adopt innovative business models, enhance healthcare outcomes, and significantly lower administrative costs. The company was founded in December 2004 and has since expanded its offerings through strategic acquisitions, including the addition of clinical capabilities from Click4Care in 2012. Headquartered in Burlington, Massachusetts, HealthEdge also operates a research and development center in Powell, Ohio, focusing on advancing its software solutions to improve connectivity among stakeholders in the healthcare delivery cycle.

Mauna Kea Technologies

Series B in 2008
Mauna Kea Technologies SA is a medical device company headquartered in Paris, France, specializing in the development and marketing of imaging technologies for the diagnosis and treatment of cancer and other diseases. Its primary product, Cellvizio, is a confocal laser endomicroscopy platform that allows real-time, in vivo microscopic visualization of tissues at the cellular level. This technology aids physicians in accurately detecting early-stage pathologies and making informed therapeutic decisions. The company operates globally, with a significant presence in Europe, the United States, and various countries in Asia and Latin America. Mauna Kea Technologies generates revenue primarily from the sales of Cellvizio products and related accessories used in medical diagnostics and research.

AngioScore

Series E in 2007
AngioScore Inc. is a company that specializes in the development, manufacturing, and marketing of innovative medical devices for the treatment of cardiovascular and peripheral artery diseases. Its primary product, the AngioSculpt Scoring Balloon Catheter, is designed to improve the efficacy of conventional angioplasty procedures. This catheter features a semi-compliant balloon combined with a unique nitinol scoring element, aimed at overcoming the limitations of traditional balloon catheters. By focusing on enhancing endovascular therapy tools, AngioScore addresses critical needs within the interventional market, contributing to advancements in the treatment of vascular diseases.

Extend Health

Series B in 2007
Extend Health specializes in offering defined contribution benefit and insurance programs tailored for employees and retirees in corporate America. The company focuses on assisting clients in selecting appropriate Medicare programs, facilitating the transition from traditional group benefits to individualized defined-contribution plans. This approach allows corporations to provide more personalized benefits to their workforce while empowering employees and retirees to make informed decisions about their healthcare options.

Click4Care

Series A in 2007
Click4Care, Inc. is a provider of medical management software designed to enhance healthcare delivery for payers, providers, and patients. Founded in 1999 and headquartered in Powell, Ohio, the company offers its flagship product, ThinkHealth, which automates workflows related to utilization management, disease management, and population health management. This software aims to enable health insurers to deliver seamless and differentiated services that improve care delivery and promote illness prevention.

Health Hero Network

Series B in 2006
Health Hero Network, Inc. develops and markets technology solutions for remote health monitoring and management. The company provides health management programs delivering personalized daily monitoring and patient education, and information to care providers. It also offers Health Buddy system that serves as the interface between patients at home and care providers, facilitating patient education and monitoring of chronic conditions. The company's Health Buddy system includes monitoring technologies, clinical information databases, Internet-enabled decision support tools, health management programs, and content development software tools. It serves hospitals, health plans, government health organizations, disease management companies, and pharmaceutical companies or universities conducting clinical trials or studies. The company was founded in 1988 and is based in Palo Alto, California. As of December 19, 2007, Health Hero Network, Inc. operates as a subsidiary of Robert Bosch GMBH.

VeraLight

Series B in 2006
VeraLight is a medical device company that was established in October 2004 to focus on a comprehensive approach to non-invasive type 2 diabetes and pre-diabetes screening with the proprietary SCOUT DS® system. Their mission is to help stem the tide of the worldwide diabetes epidemic by driving early diabetes detection, thus enabling initiation of therapies that can prevent diabetes or reduce its complications. The company develops and acquires intellectual property, products, and services that contribute to this mission.

AngioScore

Series D in 2006
AngioScore Inc. is a company that specializes in the development, manufacturing, and marketing of innovative medical devices for the treatment of cardiovascular and peripheral artery diseases. Its primary product, the AngioSculpt Scoring Balloon Catheter, is designed to improve the efficacy of conventional angioplasty procedures. This catheter features a semi-compliant balloon combined with a unique nitinol scoring element, aimed at overcoming the limitations of traditional balloon catheters. By focusing on enhancing endovascular therapy tools, AngioScore addresses critical needs within the interventional market, contributing to advancements in the treatment of vascular diseases.

Acuity Pharmaceuticals

Series B in 2004
Acuity Pharmaceuticals is a pharmaceutical company based in Philadelphia, Pennsylvania, established in 2007. It specializes in the treatment and prevention of ophthalmic diseases, particularly focusing on age-related macular degeneration (AMD) and diabetic retinopathy (DR). The company is developing small interfering RNA compounds aimed at addressing vision loss associated with these conditions. One of its key products, Cand5, is a clinical compound designed to inhibit vascular endothelial growth factor, thereby targeting adult vision loss. In June 2011, Acuity Pharmaceuticals was acquired by OPKO Health, enhancing its capabilities in the ophthalmic market.

AngioScore

Series B in 2004
AngioScore Inc. is a company that specializes in the development, manufacturing, and marketing of innovative medical devices for the treatment of cardiovascular and peripheral artery diseases. Its primary product, the AngioSculpt Scoring Balloon Catheter, is designed to improve the efficacy of conventional angioplasty procedures. This catheter features a semi-compliant balloon combined with a unique nitinol scoring element, aimed at overcoming the limitations of traditional balloon catheters. By focusing on enhancing endovascular therapy tools, AngioScore addresses critical needs within the interventional market, contributing to advancements in the treatment of vascular diseases.

InSound Medical

Series D in 2004
InSound Medical, Inc. is a privately held company located in Newark, California, specializing in the development and manufacture of advanced hearing solutions. The company is backed by prominent investors such as Johnson & Johnson, DeNovo Ventures, CMEA Ventures, and Psilos Group Managers, LLC. InSound Medical's flagship product is Lyric, an innovative invisible extended wear hearing device designed to provide users with a discreet and effective hearing solution.

deNovis

Series C in 2004
deNovis Inc. is a leading provider of advanced transaction processing and information management solutions for the health insurance and health care benefits administration industry. deNovis's highly innovative claims processing and data management software enables commercial and government health plans to reduce administrative costs, expand their range of products and services, increase speed-to-market of new products and enhance the quality of customer service. The company's flagship software product—eHD™—serves as the core administrative platform for health plans and is designed to deliver the sophistication necessary to meet both existing and emerging needs of commercial, Medicare and Medicaid healthcare benefits administrators. deNovis is also known for its technical innovations, including HICL™ technology, which allows complex healthcare transaction systems to be programmed by business analysts rather than computer programmers, using English language commands and the actual policies and business rules of the health plan. deNovis's customer roster includes large commercial insurers and the U. S. Department of Health and Human Services—the nation's largest purchaser of healthcare and a provider of healthcare benefits to almost 80 million Americans. The company's strategic alliance partners include IBM Corporation and Deloitte Consulting. deNovis enterprise solutions for health plans are available for installation at customer locations or can be delivered on an outsourced or remote-hosted basis. The company is privately held and is headquartered in Lexington, Massachusetts.

Cohesive Technologies

Series B in 2003
Cohesive Technologies Inc. designs, manufactures, and markets breakthrough liquid chromatography (LC) solutions for the drug discovery, pharmaceutical, contract research, and clinical diagnostic industries. The company has developed patented technologies and a wide range of chromatographic products designed to significantly improve productivity by accelerating the separation, purification, and analysis of molecules in bioanalysis. With a strong depth of knowledge in column chemistry, applications, engineering, software development, and quality management, Cohesive Technologies leads the industry in the research, development, and production of LC technologies that accelerate the pace of customers' drug discovery and development efforts.

Estech

Series B in 2003
ESTECH is a privately held medical device manufacturing and distribution company located in San Ramon, California. The company was founded by Arthur and Raymond Bertolero in 1996 with an emphasis on least invasive products for cardiac surgery. ESTECH has worldwide distribution and has consistently attracted goal oriented professionals who represent the brightest minds in the medical device industry. The in-depth professional experience and tireless dedication of the ESTECH Team has allowed the company to achieve rapid and sustained success in this highly competitive environment. ESTECH is proud of each employee from every department and thanks them for their contribution and support.

OneShield

Series C in 2002
OneShield, Inc. is a developer of business software solutions tailored for the global property, casualty, and broader financial services industries. Based in Marlborough, Massachusetts, with additional offices in Australia, Canada, and India, the company offers a comprehensive portfolio of cloud-based and on-premise software products, including policy management, billing, claims processing, rating, and business intelligence solutions. OneShield's software aims to streamline workflows and automate complex processes for insurers of varying sizes, providing targeted solutions and seamless upgrades to enhance efficiency and reduce costs. The company also offers implementation, client support, training, and cloud services, and has established strategic partnerships with several major technology firms. Founded in 1999, OneShield continues to evolve its offerings to meet the needs of the insurance industry.

deNovis

Series B in 2001
deNovis Inc. is a leading provider of advanced transaction processing and information management solutions for the health insurance and health care benefits administration industry. deNovis's highly innovative claims processing and data management software enables commercial and government health plans to reduce administrative costs, expand their range of products and services, increase speed-to-market of new products and enhance the quality of customer service. The company's flagship software product—eHD™—serves as the core administrative platform for health plans and is designed to deliver the sophistication necessary to meet both existing and emerging needs of commercial, Medicare and Medicaid healthcare benefits administrators. deNovis is also known for its technical innovations, including HICL™ technology, which allows complex healthcare transaction systems to be programmed by business analysts rather than computer programmers, using English language commands and the actual policies and business rules of the health plan. deNovis's customer roster includes large commercial insurers and the U. S. Department of Health and Human Services—the nation's largest purchaser of healthcare and a provider of healthcare benefits to almost 80 million Americans. The company's strategic alliance partners include IBM Corporation and Deloitte Consulting. deNovis enterprise solutions for health plans are available for installation at customer locations or can be delivered on an outsourced or remote-hosted basis. The company is privately held and is headquartered in Lexington, Massachusetts.

MRxonline

Venture Round in 2001
They are an Internet Application Service Provider (ASP) offering a suite of web-based medical billing and compliance management services. MRxonline.com has developed key business-to-business alliances that allow us to deliver the first scalable, dedicated Internet medical billing application to third-party billing companies, large practices, PHO's, IPA's, payers and practice management organizations. This new approach to practice management provides cost-effective solutions such as coding compliance monitoring and reporting at a level that is generally unavailable to physician practices. By existing entirely as an Internet application, hardware and software capital investments as well as system maintenance costs are dramatically reduced thereby allowing the physician to focus on practicing medicine, not practice management.

eMotion

Venture Round in 2000
eMotion, Inc. provides hosted business applications for managing digital media assets and marketing content. It offers hosted digital asset management software, which enables corporations, advertising agencies, and nonprofit organizations to develop, manage, and distribute media, such as digital photos, adobe or quark files, video, and audio. This product also enables users to distribute marketing materials across dispersed offices, sales teams, and vendors. The company offers its product for business applications, such as brand portals, marketing extranets, and digital asset libraries. It serves blue-chip companies, entertainment and broadcast companies, advertising agencies, and government agencies. EMotion, Inc. was formed from the merger of Cinebase Software and Picture Networks International in 2000 and is headquartered in San Francisco, California. eMotion, Inc. formerly operated as a subsidiary of Corbis Corporation. The company also has an additional office in Vienna, Virginia. As of July 10, 2008, eMotion, Inc. operates as a subsidiary of Artesia Technologies, Inc.

Active Health Managment

Series A in 2000
ActiveHealth Management is a national leader in population health management and passionate about helping every person achieve his or her best health. They deliver personalized guidance through their analytics and insights, care management, health, lifestyle and wellness programs to help their customers improve quality of care, lower healthcare costs, and drive sustained member engagement and behavior change. ActiveHealth® collaborates with employers, health plans, governments and providers currently helping more than 20 million people live their healthiest lives. ActiveHealth Management is an independent subsidiary of Aetna (NYSE: AET)

Definity Health

Venture Round in 2000
Definity Health is a company based in Saint Louis Park, Minnesota, established in 1998. It specializes in developing consumer-driven healthcare plans and activation strategies aimed at improving the healthcare experience for patients. The company creates programs and products that educate individuals, empowering them to make informed decisions regarding their treatment options. Definity Health was acquired by UnitedHealth Group, further integrating its focus on enhancing consumer engagement in healthcare.

Health Hero Network

Venture Round in 2000
Health Hero Network, Inc. develops and markets the industry's most advanced tools and technologies for delivering structured.

HealthAnswers Education

Series A in 2000
HealthAnswers Education is a developer of sales training and medical education programs for the pharmaceutical/biotech industry. HealthAnswers is a leading full-service sales training agency specializing in blended learning solutions for today's pharmaceutical and biotech sales professionals and managers. During the past 25 years we have trained tens of thousands of sales professionals across a wide range of disease categories via every live and virtual training platform available in the industry. As problem solvers, HealthAnswers partners with pharmaceutical and biotechnology leaders to determine the most effective educational and training programs that exceed expectations. We have proven expertise delivering clinical and product training, skill and performance development training, as well as Sales Force Effectiveness (SFE) activities such as needs assessments, curriculum audits, and competency model development. At HealthAnswers, we pride ourselves on our creative design while ensuring educational and learning objectives are met.

ClickThings

Venture Round in 2000
ClickThings

Health Hero Network

Venture Round in 1998
Health Hero Network, Inc. develops and markets technology solutions for remote health monitoring and management. The company provides health management programs delivering personalized daily monitoring and patient education, and information to care providers. It also offers Health Buddy system that serves as the interface between patients at home and care providers, facilitating patient education and monitoring of chronic conditions. The company's Health Buddy system includes monitoring technologies, clinical information databases, Internet-enabled decision support tools, health management programs, and content development software tools. It serves hospitals, health plans, government health organizations, disease management companies, and pharmaceutical companies or universities conducting clinical trials or studies. The company was founded in 1988 and is based in Palo Alto, California. As of December 19, 2007, Health Hero Network, Inc. operates as a subsidiary of Robert Bosch GMBH.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.